Healio Minute Podcast, Neurology Edition: Top Headlines - Week of May 30, 2022
In this week’s edition, anxiety, depression worse among older men with vision impairment; emerging therapeutics may improve outcomes in pediatric patients with rare disorders; glioblastoma presents roadblock to successful immunotherapy; and more.
Read the full coverage here:
MRI findings key pathology markers of 4R-tauopathies
Emerging therapeutics may improve outcomes in pediatric patients with rare disorders
Together Senior Health launches platform to reduce memory loss in AD, dementia
Anxiety, depression worse among older men with vision impairment
Glioblastoma presents roadblock to successful immunotherapy
References:
Carlos AF, et al. Tau histopathological lesion type correlates of structural magnetic resonance imaging and diffusion tensor imaging biomarkers in 4-repeat tauopathies. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.
Emrick L, et al. Emerging therapeutics for rare pediatric genetic disorders. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.
Gascoyne B, et al. Int Health. 2022;doi:10.1093/inthealth/ihab070
Kumthekar P. AAN year in review: neuro oncology. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.
Collapse
Read more about
